SLC5A2 and myocardial infarction: In animal studies, the transient expression of SGLT2 receptors in cardiac myocytes following the use of SGLT2 inhibitors in MI is believed to decrease infarct size by preventing cellular apoptosis and decreasing oxidative stress (20, 21).